Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Vision Study: Cerebral/ Cortical Visual Impairment (CVI)

NCT07275021 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT07275021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07275021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Vision Study: Cerebral/ Cortical Visual Impairment (CVI)
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Recruiting
Start date
July 7, 2025
Completion date
December 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

late preterm or term (37-42wks) with neonatal encephalopathy treated with hypothermia for hie, preterm less than 32wks with ivh, wmi/pvl